Association of Race and Ethnicity with Genomic Testing at a Comprehensive Cancer Center in North Carolina
Clare Meernik1, Frances Wang2, Yadurshini Raveendran2
1Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina.
Cancer Research Communications
|October 23, 2024
Abstract
Significance:
Non-Hispanic Black patients diagnosed with prostate cancer between 2014 and 2019 and treated at a comprehensive cancer center were less likely to use tumor-specific genomic testing compared with non-Hispanic White patients. Disparities in the use of precision oncology technologies should be monitored and addressed to ensure equitable cancer care.


